ProCE Banner Series

Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies

Attendees of the European Academy of Allergy and Clinical Immunology Congress (EAACI) Congress 2024 are invited to join expert faculty in Valencia, Spain to learn the latest data on new and emerging therapies to prevent HAE attacks. Faculty will explore the burdens of HAE and provide insights on individualizing care through interactive case-based discussions. 

  AMA
  | EBAC®
Who Should Attend

This program is intended for allergy/immunology healthcare professionals who manage patients with HAE, including physicians, residents, fellows, nurse practitioners, and physician associates.

All Events

Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies

Past Events

June

02

2024

11:30 AM - 1:00 PM Central European Time (CET)

In-person

Feria Valencia, Av. de les Fires, s/n, Valencia, Spain 46035

June

02

2024

12:00 PM - 1:00 PM Central European Time (CET)

In-personVirtual

Topics

Hereditary Angioedema

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Hereditary Angioneurotic Edema (HAE).

Target Audience
This program is intended for allergy/immunology healthcare professionals who manage patients with HAE, including physicians, residents, fellows, nurse practitioners, and physician associates. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Detail unmet needs of patients living with HAE
  • Incorporate patient-centered strategies to promote improved adherence and acceptance of long-term prophylaxis in HAE
  • Evaluate recent clinical data on new and emerging agents for long-term prophylactic treatment of HAE

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EBAC® Accreditation 

A blue heart and yellow starsDescription automatically generated

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1.0 external CE credit. Each participant should claim only those hours of credit that have actually been spent in the educational activity.

CME Passport

 

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account. 

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191